Prescription Required
Formulation: Tablet
Prescription Required
Formulation: Tablet
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Epzicom is a prescription HIV medication that contains two active ingredients: abacavir and lamivudine. Both medicines belong to the same general class of antiretroviral drugs and work together to reduce the amount of HIV in the body.
Epzicom is not used alone. It is prescribed as part of a combination antiretroviral treatment plan with other HIV medicines.
Epzicom is used to treat human immunodeficiency virus (HIV) infection in adults and pediatric patients who weigh at least 25 kg.
HIV attacks the immune system, especially CD4 cells, which help the body fight infections. Without treatment, HIV can continue multiplying and gradually weaken the immune system.
Epzicom helps slow this process by reducing the virus’s ability to make new copies of itself.
When HIV enters a cell, it needs to copy its genetic material so it can produce more virus.
Epzicom interferes with this copying process. By slowing viral replication, the medication helps reduce the viral load, which is the amount of HIV present in the blood.
A lower viral load helps protect the immune system and allows CD4 cells to function more effectively.
Abacavir is a nucleoside reverse transcriptase inhibitor (NRTI).
After abacavir enters the body, it is converted into an active form inside cells. This active form interferes with an HIV enzyme called reverse transcriptase.
Reverse transcriptase is necessary for HIV to copy its genetic material. When abacavir interferes with this enzyme, the virus has more difficulty producing new copies of itself.
Lamivudine is also an NRTI. Like abacavir, it becomes active inside cells and interferes with the reverse transcriptase enzyme.
Lamivudine becomes incorporated into the viral DNA that HIV is trying to build. This stops the DNA chain from continuing to grow, which interrupts viral replication.
Although abacavir and lamivudine belong to the same medication class, they are separate antiviral drugs.
Using both medicines together provides stronger control of HIV replication than relying on one medicine alone. They are also combined with additional antiretroviral medications that attack HIV in other ways.
This combination approach improves treatment effectiveness and helps reduce the risk of drug resistance.
HIV can change over time and may become resistant to medications if treatment is incomplete or doses are frequently missed.
Using several antiretroviral medicines together makes it more difficult for the virus to continue multiplying.
For this reason, Epzicom should be taken as part of the complete treatment regimen prescribed by your healthcare provider.
When taken consistently with the rest of your HIV medications, Epzicom can help:
Reduce the amount of HIV in your blood, protect your immune system, maintain or improve CD4 cell levels, and reduce the risk of complications associated with uncontrolled HIV infection.
The amount of improvement depends on your overall treatment plan and how consistently the medications are taken.
Epzicom does not cure HIV. Even when treatment lowers the viral load to very low levels, HIV remains in the body.
The goal of treatment is to keep the virus suppressed for the long term so the immune system can remain healthy and function properly.
Epzicom should be taken exactly as prescribed. Missing doses or stopping treatment without medical guidance may allow HIV to begin multiplying again.
Irregular treatment can also increase the risk that HIV will develop resistance, which may make some medications less effective in the future.
Consistent daily treatment and regular follow-up with your healthcare provider are important for maintaining good control of HIV infection.
Epzicom should be taken exactly as prescribed by your healthcare provider. It is usually taken once daily by mouth, and you can take it with or without food.
Try to take Epzicom at about the same time every day. A consistent schedule helps maintain steady levels of the medication in your body and supports better control of HIV.
Epzicom is a fixed-dose combination that contains specific amounts of two medicines: abacavir and lamivudine.
Because these ingredients are combined in one tablet, their doses cannot be adjusted separately. Your healthcare provider will determine whether the strength in Epzicom is suitable for your treatment needs before prescribing it.
For HIV treatment to work well, it is important to take Epzicom every day as directed.
Do not skip doses or take the medication only when you feel unwell. HIV can continue multiplying even when you do not have noticeable symptoms, so regular treatment is necessary to keep the virus suppressed.
Do not take more Epzicom, take it more often, or reduce your dose without speaking with your healthcare provider.
Changing the dose on your own can reduce how well the treatment works and may increase the risk of side effects or drug resistance.
Do not stop taking Epzicom or any of your other HIV medications unless your healthcare provider tells you to do so.
Stopping treatment can allow the amount of HIV in your blood to rise again. It can also increase the risk that the virus will become resistant to one or more medications, which may make future treatment more difficult.
Try to refill Epzicom before your current supply is finished. Planning ahead can help prevent missed doses or interruptions in your treatment.
Running out of medication, even for a short period, can interrupt viral suppression and make it harder to keep HIV under control.
Epzicom contains abacavir, which can cause a serious hypersensitivity reaction in some people.
If you stop taking Epzicom for any reason, contact your healthcare provider or pharmacist before restarting it. Do not restart the medication on your own.
If there is any possibility that you previously stopped because of symptoms of an allergic or hypersensitivity reaction, restarting abacavir can cause a severe and potentially life-threatening reaction.
Before starting Epzicom, patients are generally tested for the HLA-B*5701 genetic variant, which is associated with a higher risk of an abacavir hypersensitivity reaction.
Symptoms may include fever, rash, nausea, vomiting, diarrhea, abdominal pain, severe tiredness, cough, shortness of breath, or sore throat. If your healthcare provider suspects a hypersensitivity reaction, abacavir-containing medicines should generally not be restarted.
Epzicom is usually only one part of a complete antiretroviral treatment regimen.
Take the other HIV medications in your regimen exactly as prescribed. Using the full combination of medicines helps suppress HIV more effectively and reduces the chance that the virus will develop resistance.
Taking Epzicom at approximately the same time each day can make it easier to remember your dose and helps keep medication levels more consistent.
You may find it helpful to connect your dose with a regular daily activity, such as breakfast or another routine, as long as this matches the instructions from your healthcare provider.
If you frequently forget doses or have difficulty maintaining your treatment schedule, tell your healthcare provider.
Rather than changing your treatment on your own, your healthcare provider can help you find a dosing routine that is easier to follow while keeping your HIV treatment effective.
The best results come from taking Epzicom every day, at a consistent time, and together with the rest of your HIV treatment plan.
Do not skip doses, stop treatment, or restart Epzicom after an interruption without medical guidance. Consistent use helps keep the viral load low, protects the immune system, and reduces the risk of HIV becoming resistant to treatment.
Epzicom (Abacavir/Lamivudine) is available in the following forms and strength:
Epzicom can cause a serious and potentially life-threatening hypersensitivity reaction, mainly because it contains abacavir.
This reaction can occur at any time during treatment, although it is more common during the first several weeks. Symptoms may include fever, rash, nausea, vomiting, diarrhea, abdominal pain, severe tiredness, cough, shortness of breath, or sore throat.
If a hypersensitivity reaction is suspected, stop taking Epzicom and seek medical attention right away. Do not restart Epzicom or any other medication containing abacavir after a confirmed hypersensitivity reaction.
Epzicom contains lamivudine, which is also active against hepatitis B virus.
If you have hepatitis B infection and stop taking Epzicom, your hepatitis B may become worse. This can lead to a sudden increase in liver inflammation.
Your healthcare provider may monitor your liver function closely for several months after Epzicom is stopped.
Epzicom belongs to a group of medications called nucleoside reverse transcriptase inhibitors, which have rarely been associated with lactic acidosis.
Lactic acidosis is a serious buildup of lactic acid in the blood. Symptoms may include unusual weakness, severe tiredness, trouble breathing, nausea, vomiting, abdominal pain, dizziness, or a fast heartbeat.
Seek medical attention right away if you develop symptoms that may suggest lactic acidosis.
Nucleoside analogs such as the ingredients in Epzicom have also rarely been associated with severe liver enlargement with steatosis, which means a buildup of fat in the liver.
Tell your healthcare provider if you develop symptoms such as persistent nausea, abdominal pain, unusual tiredness, dark urine, or yellowing of the skin or eyes.
After starting effective HIV treatment, the immune system may become stronger and begin reacting to infections that were already present but previously caused few or no symptoms.
This is known as immune reconstitution syndrome. In some cases, symptoms of an infection or inflammatory condition may temporarily appear or become worse after starting combination antiretroviral therapy.
Tell your healthcare provider about any new or worsening symptoms after beginning Epzicom.
Epzicom should not be used in people with moderate or severe liver impairment because abacavir is processed by the liver.
If you have mild liver problems, your healthcare provider may determine that a different formulation is more appropriate so the abacavir dose can be adjusted separately.
If you are pregnant or planning to become pregnant, tell your healthcare provider before taking Epzicom.
Your healthcare provider will consider the importance of controlling HIV during pregnancy and weigh the expected benefits of treatment against any potential risks. Do not stop HIV treatment during pregnancy without medical guidance.
Yes. Epzicom can interact with certain prescription medicines, over-the-counter medications, and supplements. Tell your healthcare provider about everything you take, including vitamins and herbal products. This helps them check for possible interactions and determine whether any changes to your treatment are needed.
Store Epzicom at room temperature, away from excess heat and moisture. Keep the medication in its original container and store it in a safe place out of reach of children and pets.
If you are pregnant or planning to become pregnant, talk to your healthcare provider before taking Epzicom. Your healthcare provider will consider the benefits of controlling HIV during pregnancy and any potential risks before deciding whether Epzicom is appropriate for you.
If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose. If you have missed several doses or stopped Epzicom for any reason, contact your healthcare provider before restarting it because Epzicom contains abacavir, which can cause a serious hypersensitivity reaction.
| Generic name: | Abacavir/Lamivudine |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 600/300mg |
| Quantities Available: | 30 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Epzicom (abacavir/lamivudine) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Epzicom is commonly prescribed in a dosage of 600 mg/300 mg, taken once daily. For a 90-day supply, this means you would order 90 tablets (90 days x 1 tablet per day).
Yes, we do sell abacavir/lamivudine on our website. You can enjoy low prices when purchasing abacavir/lamivudine from us. To proceed with ordering, you will need a valid prescription from your healthcare provider. We require this to dispense the medication safely and legally. You can conveniently submit your prescription by mail, fax, or by uploading it through your online account.
Yes, we ship Epzicom (abacavir/lamivudine) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Epzicom (Abacavir/Lamivudine). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Epzicom (Abacavir/Lamivudine).
REVIEWS